AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A concise guide on selecting core crypto assets for beginners who plan to buy and hold for the long term.
28,656 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
U.S. equity markets tumbled as traders priced in a looming memory supply crisis in chipmakers, triggering a broad tec...
Analysts outline a path for Amazon to approach $300 in the next 12-15 months, anchored by cloud, ads, and Prime-drive...
As markets wobble, a Tennessee plan shows how an $800,000 portfolio can fund early retirement with smart housing, tax...
A coalition of twelve states filed a federal antitrust suit to block Paramount's $81 billion merger with Warner Bros....
A new defense-focused ETF began trading in July 2026, joining VistaShares’ space and robotics funds as investors chas...
Amazon unveils a sweeping $200 billion capex plan focused on AWS and AI infra, prompting investor debate on the compa...
The United States and its allies launched targeted strikes against facilities tied to Iran's leadership, triggering r...
A major AI cloud deal sparked a notable move in CoreWeave stock on Wednesday. This article explains what happened, wh...
Oracle delivered a standout quarter, signaling AI investments and data-center expansion can pay off. The company rais...
The U.S. sits on a $38 trillion debt path that investors and households will feel long before any sudden crunch. Poli...
Super Micro Computer faces a looming risk of removal from the S&P 500 after prosecutors charged its co-founder and tw...